Ordering Recommendation

Use for general screening in the contexts of compliance and/or abuse. A screen with reflex testing is preferred to rule out cocaine exposure. To follow up a presumptive result, the preferred test is Cocaine Metabolite, Urine, Quantitative (0090359).

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Random urine.

Specimen Preparation

Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min:  2 mL)

Storage/Transport Temperature

Room temperature.

Unacceptable Conditions

Specimens exposed to repeated freeze/thaw cycles.

Remarks
Stability

Ambient: 1 week; Refrigerated: 1 month; Frozen: 1 month

Methodology

Qualitative Enzyme Immunoassay/Quantitative Gas Chromatography-Mass Spectrometry

Performed

Sun-Sat

Reported

1-4 days

Reference Interval

Interpretive Data

Methodology: Immunoassay

Positive Cutoff: 150 ng/mL

Compliance Category

FDA

Note

If the specimen screens positive, then Confirmation/Quantitation by Mass Spectrometry (ARUP test code 0090359) will be added to confirm result. Additional charges apply.

Compare to Pain Management, Cocaine Metabolite with Confirmation with medMATCH, Urine; Pain Management, Cocaine Metabolite, Quantitative, with medMATCH, Urine.

Hotline History

N/A

CPT Codes

80307; if reflexed, add 80353 (Reflexed Alt Code: G0480 )

Components

Component Test Code* Component Chart Name LOINC
0092192 Cocaine Screen, Urine 19359-9
2012212 Screen, Urine Interpretation 54247-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Pain Management
  • Benzoylmethylecgonine
  • Cocaine
  • Crack
  • Benzoylecgonine
Cocaine, Urine Screen with Reflex to Quantitation